Activation of p53 stimulates proteasome-dependent truncation of elF4E-binding protein 1 (4E-BP1)

Biology of the Cell

Volumn 100, Issue 5, 2008, Pages 279-289

  Constantinou, Constantina ^a,b   Elia, Androulla ^a   Clemens, Michael J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Yasoo Health Ltd   (Cyprus)

Author keywords

elF4E binding protein 1 (4E BP1); Eukaryotic initiation factor 4E (elF4E); p53; Proteasome; Protein phosphorylation; Translation

Indexed keywords

BINDING PROTEIN; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4G BINDING PROTEIN 1; MESSENGER RNA; PROTEASOME; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL STRUCTURE; CONTROLLED STUDY; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; RNA TRANSLATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TUMOR; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; TUMOR SUPPRESSOR PROTEIN P53;

EUKARYOTA;

EID: 43049128163     PISSN: 02484900     EISSN: None     Source Type: Journal    
DOI: 10.1042/BC20070121     Document Type: Article

References (52)

1. Almond, J.B. and Cohen, G.M. (2002) The proteasome: a novel target for cancer chemotherapy. Leukemia 16, 433-443
2. Avdulov, S., Li, S., Michalek, V., Burrichter, D., Peterson, M., Perlman, D.M., Manivel, J.C., Sonenberg, N., Yee, D., Bitterman, P.B. and Polunovsky, V.A. (2004) Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epitheliall cells. Cancer Cell 5, 553-563
3. Averous, J. and Proud, C.G. (2006) When translation meets transformation: the mTOR story. Oncogene 25, 6423-6435
4. Baugh, J.M. and Pilipenko, E.V. (2004) 20S proteasome differentially alters translation of different mRNAs via the cleavage of eIF4F and eIF3. Mol. Cell 16, 575-586
5. Byrnes, K., White, S., Chu, Q., Meschonat, C., Yu, H., Johnson, L.W., DeBenedetti, A., Abreo, F., Turnage, R.H., McDonald, J.C. and Li, B.D. (2006) High eIF4E, VEGF, and microvessel density in stage I to III breast cancer. Ann. Surg. 243, 684-690
6. Castellvi, J., Garcia, A., Rojo, F., Ruiz-Marcellan, C., Gil, A., Baselga, J. and Cajal, S. (2006) Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107, 1801-1811
7. Chowdhury, I.H., Radonovich, M., Mahieux, R., Pise-Masison, C., Muralidhar, S. and Brady, J.N. (2003) p53 facilitates degradation of human T-cell leukaemia virus typel Tax-binding protein through a proteasome-dependent pathway. J. Gen. Virol. 84, 897-906
8. Clemens, M.J. (2004) Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23, 3180-3188
9. Constantinou, C. and Clemens, M.J. (2005) Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53. Oncogene 24, 4839-4850
10. Constantinou, C. and Clemens, M.J. (2007) Regulation of translation factors eIF4GI and 4E-BP1 during recovery of protein synthesis from inhibition by p53. Cell Death Differ. 14, 576-585
11. Constantinou, C., Bushell, M., Jeffrey, I.W., Tilleray, V., West, M., Frost, V., Hensold, J. and Clemens, M.J. (2003) p53-induced inhibition of protein synthesis is independent of apoptosis. Eur. J. Biochem. 270, 3122-3132
12. De Benedetti, A. and Graff, J.R. (2004) eIF-4E expression and its role in malignancies and metastases. Oncogene 23, 3189-3199
13. Elia, A., Constantinou, C. and Clemens, M.J. (2008) Effects of protein phosphorylation on ubiquitination and stability of the translational inhibitor protein 4E-BP1. Oncogene 27, 811-822
14. Godefroy, N., Lemaire, C., Renaud, F., Rincheval, V., Perez, S., Parvu-Ferecatu, I., Mignotte, B. and Vayssière, J.L. (2004) p53 can promote mitochondria- and caspase-independent apoptosis. Cell Death Differ. 11, 785-787
15. Graff, J.R. and Zimmer, S.G. (2003) Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin. Exp. Metastasis 20, 265-273
16. Herbert, T.P., Tee, A.R. and Proud, C.G. (2002) The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. J. Biol. Chem. 277, 11591-11596
17. Jeffrey, I.W., Elia, A., Bornes, S., Tilleray, V.J., Gengatharan, K. and Clemens, M.J. (2006) Interferon-α induces sensitization of cells to inhibition of protein synthesis by tumour necrosis factor-related apoptosis-inducing ligand. FEBS J. 272, 3698-3708
18. Jiang, H.Y. and Wek, R.C. (2005) Phosphorylation of eIF2alpha reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J. Biol. Chem. 280, 14189-14202
19. Jin, S., Kalkum, M., Overholtzer, M., Stoffel, A., Chait, B.T. and Levine, A.J. (2003) CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals. Genes Dev. 17, 359-367
20. Kaluzova, M., Kaluz, S., Lerman, M.I. and Stanbridge, E.J. (2004) DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1 alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX. Mol. Cell. Biol. 24, 5757-5766
21. Kisselev, A.F., Garcia-Calvo, M., Overkleeft, H.S., Peterson, E., Pennington, M.W., Ploegh, H.L., Thornberry, N.A. and Goldberg, A.L. (2003) The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites. J. Biol. Chem. 278, 35869-35877
22. Kisselev, A.F., Callard, A. and Goldberg, A.L. (2006) Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J. Biol. Chem. 281, 8582-8590
23. Lee, J.W., Choi, J.J., Lee, K.M., Choi, C.H., Kim, T.J., Lee, J.H., Kim, B.G., Ahn, G., Song, S.Y. and Bae, D.S. (2005) eIF-4E expression is associated with histopathologic grades in cervical neoplasia. Hum. Pathol. 36, 1197-1203
24. Li, S., Sonenberg, N., Gingras, A.C., Peterson, M., Avdulov, S., Polunovsky, V.A. and Bitterman, P.B. (2002) Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency. Mol. Cell. Biol. 22, 2853-2861
25. Lin, S.W., Cook, M., Finnberg, N., Bernhard, E., Baldwin, D. and El Dairy, W.S. (2004) p53-dependent induction of serine proteases in irradiated mouse colon. Cancer Biol. Ther. 3, 1290-1297
26. Lin, T.-A., Kong, X., Saltiel, A.R., Blackshear, P.J. and Lawrence, Jr, J.C. (1995) Control of PHAS-1 by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway. J. Biol. Chem. 270, 18531-18538
27. Lorenzo, H.K. and Susin, S.A. (2004) Mitochondrial effectors in caspase-independent cell death. FEBS Lett. 557, 14-20
28. Ludwig, H., Khayat, D., Giaccone, G. and Facon, T. (2005) Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies. Cancer 104, 1794-1807
29. Mamane, Y., Petroulakis, E., Rong, L.W., Yoshida, K., Ler L.W. and Sonenberg, N. (2004) elF4E - from translation to transformation. Oncogene 23, 3172-3179
30. Mamane, Y., Petroulakis, E., LeBacquer, O. and Sonenberg, N. (2006) mTOR, translation initiation and cancer. Oncogene 25, 6416-6422
31. Matthews-Greer, J., Caldito, G., De Benedetti, A., Herrera, G.A., Dominguez-Malagon, H., Chanona-Vilchis, J. and Turbat-Herrera, E.A. (2005) elF4E as a marker for cervical neoplasia. Appl. Immunohistochem. Mol. Morphol. 13, 367-370
32. McClusky, D.R., Chu, Q., Yu, H., DeBenedetti, A., Johnson, L.W., Meschonat, C., Turnage, R., McDonald, J.C., Abreo, F. and Li, B.D. (2005) A prospective trial on initiation factor 4E (elF4E) overexpression and cancer recurrence in node-positive breast cancer. Ann. Surg. 242, 584-590
33. Moerke, N.J., Aktas, H., Chen, H., Cantel, S., Reibarkh, M.Y., Fahmy, A., Gross, J.D., Degterev, A., Yuan, J., Chorev, M. et al. (2007) Small-molecule inhibition of the interaction between the translation initiation factors elF4E and elF4G. Cell 128, 257-267
34. Moorthy, A.K., Savinova, O.V., Ho, J.Q., Wang, V.Y., Vu, D. and Ghosh, G. (2006) The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner. EMBO J. 25, 1945-1956
35. Mungamuri, S.K., Yang, X., Thor, A.D. and Somasundaram, K. (2006) Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res. 66, 4715-4724
36. Petroulakis, E., Mamane, Y., Le Bacquer, O., Shahbazian, D. and Sonenberg, N. (2006) mTOR signaling: implications for cancer and anticancer therapy. Br. J. Cancer 94, 195-199
37. Proud, C.G. (2005) The eukaryotic initiation factor 4E-binding proteins and apoptosis. Cell Death Differ. 12, 541-546
38. Rojo, F., Najera, L., Lirola, J., Jimenez, J., Guzman, M., Sabadell, M.D., Baselga, J. and Cajal, S. (2007) 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clin. Cancer Res. 13, 81-89
39. Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C. and Pandolfi, P.P. (2004) The translation factor elF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat. Med. 10, 484-486
40. Sadot, E., Geiger, B., Oren, M. and Ben-Ze'ev, A. (2001) Down-regulation of beta-catenin by activated p53. Mol. Cell. Biol. 21, 6768-6781
41. Saito, T., Onuki, R., Fujita, Y., Kusakawa, G., Ishiguro, K., Bibb, J.A., Kishimoto, T. and Hisanaga, S. (2003) Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation. J. Neurosci. 23, 1189-1197
42. Sorokin, A.V., Selyutina, A.A., Skabkin, M.A., Guryanov, S.G., Nazimov, I.V., Richard, C., Th'ng, J., Yau, J., Sorensen, P.H., Ovchinnikov, L.P. and Evdokimova, V. (2005) Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response. EMBO J. 24, 3602-3612
43. Strudwick, S. and Borden, K.L.B. (2002) The emerging roles of translation factor elF4E in the nucleus. Differentiation 70, 10-22
44. Su, K., Roos, M.D., Yang, X., Han, I., Paterson, A.J. and Kudlow, J.E. (1999) An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J. Biol. Chem. 274, 15194-15202
45. Tee, A.R. and Proud, C.G. (2000) DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling. Oncogene 19, 3021-3031
46. Tee, A.R. and Proud, C.G. (2001) Staurosporine inhibits phosphorylation of translational regulators linked to mTOR. Cell Death Differ. 8, 841-849
47. Tee, A.R. and Proud, C.G. (2002) Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol. Cell. Biol. 22, 1674-1683
48. Tilleray, V., Constantinou, C. and Clemens, M.J. (2006) Regulation of protein synthesis by inducible wild-type p53 in human lung carcinoma cells. FEBS Lett. 580, 1766-1770
49. Vabulas, R.M. and Harti, F.U. (2005) Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 310, 1960-1963
50. Wendel, H.G., De Stanchina, E., Fridman, J.S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J. and Lowe, S.W. (2004) Survival signalling by Akt and elF4E in oncogenesis and cancer therapy. Nature 428, 332-337
51. Wojcik, C. (2002) Regulation of apoptosis by the ubiquitin and proteasome pathway. J. Cell. Mol. Med. 6, 25-48
52. Yuan, X.M., Li, W., Dalen, H., Lotem, J., Kama, R., Sachs, L. and Brunk, U.T. (2002) Lysosomall destabilization in p53-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 99, 6286-6291